David A. Siegel Novan, Inc. Transaction History

Two Sigma Advisers, LP

  • $41.3 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$2.29 - $3.86 $110,149 - $185,666
-48,100 Reduced 60.2%
31,800 $74,000
Q1 2022

May 16, 2022
SELL
$2.95 - $4.41 $26,550 - $39,690
-9,000 Reduced 10.12%
79,900 $315,000
Q4 2021

Feb 14, 2022
BUY
$4.03 - $8.15 $358,267 - $724,535
88,900 New
88,900 $371,000

About Novan, Inc.

NOVN Quotes by TradingView
  • Ticker NOVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,281,600
  • Market Cap $638K
  • Description
  • Novan, Inc., a pre-commercial nitric oxide-based pharmaceutical company, focuses on dermatology and anti-infective therapies. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-sp...
More about NOVN
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email